Login / Signup

New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion.

Ming-Feng LiHuei-Lung LiangChia-Ling ChiangWei-Lun TsaiWen-Chi ChenCheng-Chung TsaiI-Shu Chen
Published in: Journal of personalized medicine (2022)
Our new HAIC regimen is effective in treating Vp4 HCC patients. Additional sorafenib use with our new HAIC regimen provided no survival benefit.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • low dose
  • cell migration
  • squamous cell carcinoma
  • radiation therapy